Trial site
Velocity Clinical Research, Dallas
- 28running trials
- 23closed trials
The trials here
What the 51 trials at this site are about, from their registry records.
- Conditions
- Obesity36 trials
- Type 2 diabetes29 trials
- Type 1 diabetes6 trials
- Chronic kidney disease2 trials
- Obstructive sleep apnoea2 trials
- Coronary artery disease1 trial
- Cushing's syndrome1 trial
- Diabetic neuropathy1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- Migraine1 trial
- Peripheral artery disease1 trial
- and 1 more
- Phase
- Phase 326 trials
- Phase 224 trials
- Status
- Completed21 trials
- Active, not recruiting19 trials
- Recruiting7 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company32 trials
- Carmot Therapeutics, Inc.3 trials
- Pfizer2 trials
- Regeneron Pharmaceuticals2 trials
- Amgen1 trial
- and 11 more
Running trials
Not yet recruiting
Recruiting
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
Active, not recruiting
Active, not recruiting
A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults
Recruiting
Active, not recruiting
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Not yet recruiting
Active, not recruiting
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
Recruiting
Active, not recruiting
Active, not recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Active, not recruiting
Active, not recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes6 recruiting
- Obesity5 recruiting
- Cushing's syndrome1 recruiting
- Migraine1 recruiting
- Obstructive sleep apnoea1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Terminated
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Withdrawn
Completed
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
Completed
Completed
Recruiting
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
Completed
Completed
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
Completed
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026